Dr. Summer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
834 Walnut St
Ste 650
Philadelphia, PA 19107Phone+1 215-955-5161Fax+1 215-923-6003- Is this information wrong?
Summary
- Dr. Ross Summer is a pulmonologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Louisiana State University School of Medicine and has been in practice 21 years. He specializes in critical care and respiratory medicine with specific focus on the care and treatment of patients with interstitial lung disease. He has more than 100 publications and approximately 7500 citings.
Education & Training
- Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2003
- Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
- Louisiana State University School of Medicine in New OrleansClass of 1996
Certifications & Licensure
- PA State Medical License 2011 - 2024
- MA State Medical License 1999 - 2014
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis Start of enrollment: 2018 Sep 04
Roles: Contact
Publications & Presentations
PubMed
- Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;BMC Pulmonary Medicine. 2024 Mar 20
- Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand, Daniel F Dilling, Ross Summer, Steven R Duncan> ;Research Square. 2024 Feb 28
- Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.Suliman, S. A., Ross Summer, Jamie L Todd, Megan L Neely, L Jason Lobo, Andrew Namen, L Kristin Newby, Shirin Shafazand, Sally Suliman, Christian Hesslinger, Sascha Ke...> ;Respiratory Research. 2024 Jan 25
- Join now to see all
Press Mentions
- Hermansky-Pudlak Syndrome-2 Alters Mitochondrial Homeostasis in the Alveolar Epithelium of the LungFebruary 8th, 2021
- Increasing Lipid Production Could Be Key to New Pulmonary Fibrosis Treatment, Study SaysMarch 12th, 2018
Grant Support
- Adiponectin Inhibits Activation And Injury Of Lung EndotheliumNational Heart, Lung, And Blood Institute2011
- The Identification And Study Of A Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2007–2010
- The Identification And Study- Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2006
Professional Memberships
- Member
Hospital Affiliations
- Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: